Lataa...
Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes
BACKGROUND: Skin autofluorescence (SAF) is a non-invasive marker of tissue accumulation of advanced glycation endproducts (AGE). Recently, we demonstrated in the general population that elevated SAF levels predict the development of type 2 diabetes (T2D), cardiovascular disease (CVD) and mortality....
Tallennettuna:
| Julkaisussa: | BMC Endocr Disord |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7802158/ https://ncbi.nlm.nih.gov/pubmed/33435948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-00676-4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|